News & Filings
GRANULES \u2014 Recent Activity
5 items in the last 14 days
Granules India Ltd (BOM:532482) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and ...
Granules India Ltd (BOM:532482) reports a robust 22% revenue increase, regulatory milestones, and strategic focus on high-value segments amid operational challenges.
Click to open →
Granules India quarterly profit jumps on strong demand in North America, Europe
Jan 23 (Reuters) - Paracetamol maker Granules India reported a 28% jump in third-quarter profit on Friday, driven by strong demand in its key European and North American markets.
Click to open →
Granules India Ltd (BOM:532482) Q2 2026 Earnings Call Highlights: Robust Revenue Growth Amid ...
Granules India Ltd (BOM:532482) reports a 34% revenue increase in Q2 FY26, driven by strong performance in North America and Europe, despite ongoing FDA compliance issues.
Click to open →
Granules India posts higher quarterly profit on strong North America, Europe sales
(Reuters) -Paracetamol maker Granules India reported a 34% jump in its second-quarter profit on Thursday, driven by strong demand in its key European and North American markets.
Click to open →
Granules India Ltd (BOM:532482) Q4 2025 Earnings Call Highlights: Strategic Expansions and ...
Granules India Ltd (BOM:532482) reports revenue growth and strategic advancements despite facing operational hurdles and regulatory challenges.
Click to open →
Get alerts for important filings
Add GRANULES to your watchlist for board meeting & dividend alerts.
Open analysis →News from yfinance + BSE corporate announcements. Importance scoring is automated. YieldIQ is not registered with SEBI as an investment adviser.